No Data
No Data
AstraZeneca's Datroway Approved in U.S. for HER2-negative Breast Cancer Patients
Unusual Options Activity: MSTR, HRL and Others Attract Market Bets, MSTR V/OI Ratio Reaches 129.7
AstraZeneca, Daiichi Sankyo Antibody-drug Conjugate Dato-DXd Gains FDA Nod
AstraZeneca Said to Have Changed Management of Its China Unit
Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks
Express News | 'Ozempic Is In The Next Round Of Medicare Drug Price Negotiations. See The Full List Of 15 Medications' - CNBC
loading...